Skip to main content
Fig. 1 | European Journal of Medical Research

Fig. 1

From: FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinoma

Fig. 1

The expression of FANCD2 in different cancers. A The expression of FANCD2 in different cancers and adjacent normal tissues in the TCGA database. B The expression of FANCD2 in different cancers and normal tissues of GTEx. CHOL, cholangiocarcinoma; COAD, colon adenocarcinoma; LIHC, Liver hepatocellular carcinoma; PAAD, pancreatic adenocarcinoma; READ, rectum adenocarcinoma; STAD, stomach adenocarcinoma

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us